Figure 1.

Classification model to determine company interests in patient organisation funding. Note: An interest is when there is, or could be perceived to be, an opportunity for a pharmaceutical company to benefit in the disease area where the patient organisation operates. ICD-11, International Classification of Diseases V.11.